RxDoctor Payments DataLook up a doctor →

Carrie Nash, DO

Family Medicine · Brandon, MSNPI 1851590871

Payments from drug & device makers

$21,306in general payments, 2019–2025

Across 1,115 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Pfizer$2K
  • Novo Nordisk$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Lilly USA, LLC$1K
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)189$2,914
AstraZeneca(2 entities)89$2,369
Pfizer125$1,981
Novo Nordisk82$1,765
Takeda Pharmaceuticals U.S.A., Inc.66$1,050
Lilly USA, LLC74$1,040
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC41$864
Teva Pharmaceuticals USA, Inc.28$807
Astellas Pharma US Inc38$786
Boehringer Ingelheim35$649
Amgen36$532
Bayer32$482
GSK31$459
Abbott22$448
Axsome Therapeutics, Inc.11$419
Merck21$329
Sanofi-aventis U.S. LLC13$270
Amarin Pharma, Inc.10$258
Esperion Therapeutics, Inc.8$233
Corcept Therapeutics10$207
Tris Pharma Inc11$194
Biohaven Pharmaceuticals, Inc.11$192
Kowa Pharmaceuticals America, Inc.6$191
Idorsia Pharmaceuticals US Inc8$181
Biohaven Pharmaceutical Holding Company Ltd.10$181
Nestle Healthcare Nutrition Inc.3$159
Ironwood Pharmaceuticals, Inc7$149
Lundbeck LLC2$147
Avanir Pharmaceuticals, Inc.3$147
Novartis9$140
Sumitomo Pharma America, Inc.9$130
Astellas Pharma Global Development1$130
Eisai Inc.9$123
Edwards Lifesciences1$116
Exact Sciences6$94
Supernus Pharmaceuticals, Inc.5$92
Kyowa Kirin, Inc.1$87
Inari Medical, Inc.1$82
Johnson & Johnson5$75
Phathom Pharmaceuticals, Inc.4$72
Shield Therapeutics Inc4$64
Topcon Healthcare Solutions, Inc.1$59
Sunovion Pharmaceuticals Inc.4$58
Jazz Pharmaceuticals Inc.3$56
SK Life Science, Inc.1$55
Insmed, Inc.1$47
Currax Pharmaceuticals LLC2$41
Arbor Pharmaceuticals, Inc.3$34
Inspire Medical Systems, Inc.1$33
Corium, LLC2$32
Promius Pharma LLC2$28
Otsuka America Pharmaceutical, Inc.2$27
E.r. Squibb & Sons, L.L.C.2$24
Nalpropion Pharmaceuticals LLC2$22
Upsher-smith Laboratories LLC1$21
Ardelyx, Inc.1$20
Aimmune Therapeutics, Inc.1$18
Vertex1$17
Dexcom, Inc.1$17
Xeris Pharmaceuticals, Inc.1$15

How this compares

$21,306 in reported general payments places this provider in the 95th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$186,403
Medicare patients
625
Services billed
5,516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Brandon

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →